Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer
GILTEDX
GILTEDX is a medicine used to treat FLT3-mutated acute myeloid leukemia (AML).
Trade name
GILTEDX
Manufacturer
DAXIONG
Main ingreadient
GILTERITINIB
Specification
40mg*84 Tablets
Logistics
Please negotiate the logistics method with customer service, customer service Whatsapp/Wechat
Reminder
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.
GILTEDX is an antineoplastic inhibitor of RTKs such as FMS-related tyrosine kinase 3 (FLT3, STK1, or FLK2), AXL (UFO or JTK11), and anaplastic lymphoma kinase (ALK or CD246). GILTEDX binds to and inhibits FLT3, AXL, and ALK in both wild-type and mutant forms. This could impair the FLT3, AXL, and ALK signaling pathways, slowing tumor cell development in cancer cell types that overexpress these RTKs. GILTEDX is used to treat FLT3-mutated acute myeloid leukemia (AML).
FLT3, AXL, and ALK are overexpressed or mutated in many cancer cell types. They're essential for tumor cell proliferation and survival.